“Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N -methyl-D-aspartate receptor in anxiety: a literature review” (2017) Brazilian Journal of Pharmaceutical Sciences, 53(1), p. e16102-. doi:10.1590/s2175-97902017000116102.